The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’

The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’

COVID-19 worsens the course of cerebrovascular diseases (CVD), including chronic cerebral ischaemia (CCI). The Actovegin drug, which has long been widely used in CCI treatment, has an antioxidant and endothelium protective effect. It makes sense to study the effect of Actovegin therapy on the clinic...

Full description

Bibliographic Details
Main Author: V. V. Kovalchuk
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-02-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
covid-19
treatment
cerebrovascular diseases
chronic cerebral ischaemia
cognitive impairment
actovegin
Online Access:https://nnp.ima-press.net/nnp/article/view/1508

Internet

https://nnp.ima-press.net/nnp/article/view/1508

Similar Items